83 results on '"Aceto, Mario D."'
Search Results
2. Pharmacological studies with a nonpeptidic, delta-opioid (−)-(1 R,5 R,9 R)-5,9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((−)-NIH 11082)
3. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice
4. l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice
5. NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action
6. Pharmacological studies with a nonpeptidic, delta-opioid (−)-(1R,5R,9R)-5,9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((−)-NIH 11082)
7. Effects of JDTic, a selective κ-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model
8. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism
9. Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist
10. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist
11. Discriminative Stimulus, Reinforcing, Physical Dependence, and Antinociceptive Effects of Oxycodone in Mice, Rats, and Rhesus Monkeys
12. The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
13. N-(Trifluoromethyl)benzyl substituted N-Normetazocines and N-Norketobemidones
14. Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2
15. Discriminative stimulus properties of the optical isomers of nicotine
16. Differences in antiwrithing activity of morphine and nalorphine over time and in slopes of the dose-response lines
17. The effects of certain psychotropic agents on the conditioned emotional response behavior pattern of the albino rat
18. Effects of reserpine and chlorpromazine on rats subjected to experimental stress
19. Drugs and avoidance performance
20. Similarities in effects of barbiturates and mild tranquilizers on activity in mice
21. Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.
22. MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys.
23. Central actions of nicotine.
24. The Antinicotinic Effects of Drugs with Clinically Useful Sedative-Antianxiety Properties.
25. THE CORONARY VASODILATORY EFFECTS OF 2-AMINOETHYL-NITRATE p-TOLUENESULFONATE.
26. THE EFFECTS OF ISOSORBIDE DINITRATE ON CORONARY VASCULAR RESISTANCE.
27. N-cyclohexylethyl- N-noroxymorphindole: a μ-Opioid preferring analogue of naltrindole
28. Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities.
29. Cynomolgus monkeys and morphine tolerance and dependence
30. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor
31. Nicotine binding sites and their localization in the central nervous system
32. Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey
33. The effect of sodium ion on antinociception and opiate binding [formula omitted][formula omitted]
34. Potential Long Acting Opiate Antagonists: Preparation, Pharmacological Activity, and Opiate-Receptor Binding of N-Substituted 2′-Hydroxy-5-methyl-9α-propyl-6,7-benzomorphans
35. Pharmacological Actions of the Racemic and the Enantiomeric 1,4-Dimethyl-IO-Hydroxy-2,3,4,5,6,7-Hexahydro-1,6-Methano-IH-4-Benzazonines (C-Homobenzomorphans)
36. Effects of β-funaltrexamine (β-FNA) on morphine dependence in rats and monkeys
37. Antinociceptive studies of the optical isomers of N-allylnormetazocine (SKF 10,047)
38. Rapid and brief tolerance to (+)- and (−)-nicotine in unanesthetized rats
39. Effect of various agents on reserpine-induced blepharoptosis
40. Nicotine's opioid and anti-opioid interactions: Proposed role in smoking behavior
41. Dynorphin-(1–13): Effects in nontolerant and morphine-dependent rhesus monkeys
42. The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
43. Discriminative stimulus reinforcing and physical dependence properties of acetorphan
44. 640 - COMPARATIVE STUDY OF THE EFFECTS OF TWO NARCOTIC ANTAGONISTS NALOXONE AND NALORPHINE ON DEVELOPING MORPHINE DEPENDENCE IN RHESUS MONKEY
45. 1149 - ANALGESIC AND PHYSICAL DEPENDENCE LIABILITY OF TWO NEW ESTERS OF N-METHYLPIPERIDINE
46. Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.
47. Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.
48. Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines.
49. Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.
50. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.